US Stock MarketDetailed Quotes
SNSE Sensei Biotherapeutics
- 0.970
- -0.013-1.31%
Close Apr 19 16:00 ET
24.32MMarket Cap-795P/E (TTM)
1.020High0.933Low23.78KVolume0.940Open0.983Pre Close23.33KTurnover0.15%Turnover RatioLossP/E (Static)25.07MShares1.72052wk High0.37P/B15.92MFloat Cap0.51052wk Low--Dividend TTM16.41MShs Float26.500Historical High--Div YieldTTM8.85%Amplitude0.510Historical Low0.981Avg Price1Lot Size
About Sensei Biotherapeutics Company
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Company Profile
SymbolSNSE
Company NameSensei Biotherapeutics
Listing DateFeb 4, 2021
Issue Price19.00
Founded1999
CEOMr. John Celebi
MarketNASDAQ
Employees27
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1405 Research Boulevard`,Suite 125
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-243-8000
Websitehttp://senseibio.com
Company Executives
- Name
- Position
- Salary
- John Celebi
- President, Chief Executive Officer and Director
- 1.57M
- Edward Van der Horst
- Chief Scientific Officer
- 654.40K
- Patrick Gallagher
- Chief Business Officer
- --
- William R. Ringo, Jr
- Chairman of the Board
- 200.08K
- Thomas G. Ricks
- Independent Director
- 93.60K
- Kristian Humer
- Independent Director
- 75.03K
- Dr. Jessie M. English, PhD
- Independent Director
- 79.03K
- Dr. James Peyer, PhD
- Independent Director
- 88.93K
- Bob Holmen
- Independent Director
- 87.41K
- Dr. Deneen Vojta
- Independent Director
- 81.61K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg